Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianquan Zhan

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Oxidative Medicine and Cellular Longevity|March 4, 2022
Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related GenesNa Li, Xianquan Zhan
The EPMA Journal|August 28, 2020
Identification of pathology-specific regulators of m<sup>6</sup>A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicineNa Li, Xianquan Zhan
Mass Spectrometry Reviews|February 15, 2023
Mass spectrometry analysis of phosphotyrosine-containing proteinsJiajia Li, Xianquan Zhan
Oxidative Medicine and Cellular Longevity|May 2, 2022
Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian CancerLiang Shen, Xianquan Zhan
The EPMA Journal|June 17, 2017
Pattern recognition for predictive, preventive, and personalized medicine in cancerTingting Cheng, Xianquan Zhan
Mass Spectrometry Reviews|February 6, 2020
MASS SPECTROMETRY-BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERSNa Li, Xianquan Zhan
The EPMA Journal|June 19, 2020
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axesNa Li, Xianquan Zhan
The EPMA Journal|August 30, 2019
Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancerNa Li, Xianquan Zhan
The EPMA Journal|July 2, 2019
Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomicsNa Li, Xianquan Zhan
The EPMA Journal|March 9, 2018
The crucial role of multiomic approach in cancer research and clinically relevant outcomesMiaolong Lu, Xianquan Zhan
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Oxidative Medicine and Cellular Longevity|March 4, 2022
Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related GenesNa Li, Xianquan Zhan
The EPMA Journal|August 28, 2020
Identification of pathology-specific regulators of m<sup>6</sup>A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicineNa Li, Xianquan Zhan
Mass Spectrometry Reviews|February 15, 2023
Mass spectrometry analysis of phosphotyrosine-containing proteinsJiajia Li, Xianquan Zhan
Oxidative Medicine and Cellular Longevity|May 2, 2022
Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian CancerLiang Shen, Xianquan Zhan
The EPMA Journal|June 17, 2017
Pattern recognition for predictive, preventive, and personalized medicine in cancerTingting Cheng, Xianquan Zhan
Mass Spectrometry Reviews|February 6, 2020
MASS SPECTROMETRY-BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERSNa Li, Xianquan Zhan
The EPMA Journal|June 19, 2020
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axesNa Li, Xianquan Zhan
The EPMA Journal|August 30, 2019
Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancerNa Li, Xianquan Zhan
The EPMA Journal|July 2, 2019
Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomicsNa Li, Xianquan Zhan
The EPMA Journal|March 9, 2018
The crucial role of multiomic approach in cancer research and clinically relevant outcomesMiaolong Lu, Xianquan Zhan
Pageof 12